We’ve all seen them and some of us have one at home: picky eaters. A toddler that just won’t eat, no matter what you put on ...

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a ...

The esophagus is the muscular tube that connects the mouth to the stomach and brings food into the body. In eosinophilic ...

Eupraxia Pharmaceuticals Inc., a clinical-stage biotechnology company leveraging its proprietary DiffuSphere technology to ...

A condition known as eosinophilic esophagitis, or EoE, affects one in 1,500 kids. They actually have an allergic reaction ...

CALY-002 is under clinical development by Novartis and currently in Phase I for Eosinophilic Esophagitis. According to GlobalData, Phase I drugs for Eosinophilic Esophagitis have an 86% phase ...

Fasenra was approved in 2017 but AZ came up short in its attempts to expand its label to chronic obstructive pulmonary ...

The FDA has approved Fasenra® (benralizumab) for the treatment of adult patients with eosinophilic granulomatosis with polyangiitis.

Many parents struggle with school lunches when their kids have multiple food allergies. The information may also help with ...

Recommendation based on a Phase 3 trial showing a significantly greater proportion of children on Dupixent achieved histological remission ...

More than half (60%) of patients in latest trial reached active remission and 41% stopped taking corticosteroid entirely.

Dupixent recommended for EU approval by the CHMP to treat eosinophilic esophagitis in children as young as 1 year old Recommendation based on a phase 3 study showing a significantly greater proportion ...